DE60214412D1 - Simplifizierte sarcodictyn-derivate als anti-tumor-mittel - Google Patents

Simplifizierte sarcodictyn-derivate als anti-tumor-mittel

Info

Publication number
DE60214412D1
DE60214412D1 DE60214412T DE60214412T DE60214412D1 DE 60214412 D1 DE60214412 D1 DE 60214412D1 DE 60214412 T DE60214412 T DE 60214412T DE 60214412 T DE60214412 T DE 60214412T DE 60214412 D1 DE60214412 D1 DE 60214412D1
Authority
DE
Germany
Prior art keywords
derivatives
simplified
sarcodictyn
tumor agents
sarcodictyin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60214412T
Other languages
English (en)
Other versions
DE60214412T2 (de
Inventor
Nicola Mongelli
Maria Menichincheri
Marina Ciomei
Cesare Gennari
Joachim Telser
Raphael Beumer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Milano
Pfizer Italia SRL
Original Assignee
Universita degli Studi di Milano
Pfizer Italia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Milano, Pfizer Italia SRL filed Critical Universita degli Studi di Milano
Publication of DE60214412D1 publication Critical patent/DE60214412D1/de
Application granted granted Critical
Publication of DE60214412T2 publication Critical patent/DE60214412T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/32—All rings being cycloaliphatic the ring system containing at least eleven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60214412T 2001-09-14 2002-09-06 Simplifizierte sarcodictyn-derivate als anti-tumor-mittel Expired - Fee Related DE60214412T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0122257 2001-09-14
GBGB0122257.9A GB0122257D0 (en) 2001-09-14 2001-09-14 Simplified sarcodictyin derivatives
PCT/EP2002/010038 WO2003024529A1 (en) 2001-09-14 2002-09-06 Simplified sarcodictyn derivatives as anti-tumor agents

Publications (2)

Publication Number Publication Date
DE60214412D1 true DE60214412D1 (de) 2006-10-12
DE60214412T2 DE60214412T2 (de) 2007-09-20

Family

ID=9922112

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60214412T Expired - Fee Related DE60214412T2 (de) 2001-09-14 2002-09-06 Simplifizierte sarcodictyn-derivate als anti-tumor-mittel

Country Status (11)

Country Link
US (1) US20050038112A1 (de)
EP (1) EP1439885B1 (de)
JP (1) JP2005519864A (de)
AT (1) ATE337826T1 (de)
CA (1) CA2460244A1 (de)
DE (1) DE60214412T2 (de)
DK (1) DK1439885T3 (de)
ES (1) ES2269768T3 (de)
GB (1) GB0122257D0 (de)
PT (1) PT1439885E (de)
WO (1) WO2003024529A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337671A (zh) * 2016-12-31 2017-11-10 陕西科技大学 一类具有抗肿瘤活性的橙皮素氮杂肉桂酸酯化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9509888D0 (en) * 1995-05-16 1995-07-12 Pharmacia Spa Terpenoidic derivatives useful as antitumour agents
US5965718A (en) * 1997-10-24 1999-10-12 The Scripps Research Institute Analogs of sarcodictyin and eleutherobin

Also Published As

Publication number Publication date
GB0122257D0 (en) 2001-11-07
ES2269768T3 (es) 2007-04-01
ATE337826T1 (de) 2006-09-15
JP2005519864A (ja) 2005-07-07
CA2460244A1 (en) 2003-03-27
PT1439885E (pt) 2007-01-31
EP1439885B1 (de) 2006-08-30
DK1439885T3 (da) 2007-01-08
WO2003024529A1 (en) 2003-03-27
DE60214412T2 (de) 2007-09-20
US20050038112A1 (en) 2005-02-17
EP1439885A1 (de) 2004-07-28

Similar Documents

Publication Publication Date Title
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
TW200505924A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
NO20054842L (no) Kjemiske forbindelser
TW200407326A (en) Pyrimido compounds having antiproliferative activity
NO20055891L (no) Kinazolinderivater som aurorakinaseinhibitorer
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
PT1212312E (pt) Novos derivados de flavonas xantonas e cumarinas
ATE396986T1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
NO20054360L (no) Nye oxazolderivater, deres fremstilling og anvendelse som farmasotiske preparater
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
TW200736220A (en) Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
DE60221104D1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
DE60214412D1 (de) Simplifizierte sarcodictyn-derivate als anti-tumor-mittel
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
TW200701980A (en) Benzylether derivatives, their manufacture and use as pharmaceutical agents
TW200626590A (en) Triazole derivatives, their manufacture and use as pharmaceutical agents
TW200626589A (en) Azole derivatives, their manufacture and use as pharmaceutical agents
MX2009004187A (es) Derivados de heterociclil piridil sulfonamida, su manufactura y uso como agentes farmaceuticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee